National Centers for Biomedical Imaging and Bioengineering (NCBIB) (P41 Clinical Trials Optional)
Funding available for national centers developing and sharing new biomedical technologies for researchers, with an emphasis on clinical trials.
Funder: National Institutes of Health
Due Dates: May 25, 2025 | September 25, 2025 | January 25, 2026 | May 25, 2026 | September 25, 2026
Funding Amounts: Typical direct costs: $600,000–$750,000/year (plus up to $500,000 for special-purpose equipment over 5 years); project period up to 5 years; max 15 years total funding per center.
Summary: Supports national resource centers to develop, disseminate, and train users in innovative biomedical imaging and bioengineering technologies for broad research and clinical impact.
Key Information: Letter of intent required 12 weeks before application; limited submission; early-stage clinical trials only (Phase I or equivalent).
Description
This opportunity funds National Centers for Biomedical Imaging and Bioengineering (NCBIB) as Biomedical Technology Resource Centers (BTRCs). These centers are expected to be national resources, developing and disseminating innovative technologies that address the needs of basic, translational, and/or clinical researchers. Centers must:
- Conduct cutting-edge technology research and development (TR&D) projects.
- Make technologies broadly available to the research community.
- Train users at all levels (from clinicians to students) in the use of these technologies.
- Disseminate new methods and tools widely.
Centers are expected to have a nationwide impact, with collaborative and service projects distributed across the U.S. The program supports early-stage clinical trials (Phase I, first-in-human, safety, feasibility, or other small trials that inform technology development), but not later-stage or pivotal trials.
